Edition:
United Kingdom

Advanced Medical Equipment & Technology

Page 1

ScandiDos Q2 EBITDA Loss At SEK ‍2.3​ Mln

Friday, 15 Dec 2017

Dec 15 (Reuters) - SCANDIDOS AB ::Q2 NET SALES SEK 10.5 MILLION VERSUS SEK 11.3 MILLION YEAR AGO.Q2 EBITDA LOSS SEK ‍2.3​ MILLION VERSUS LOSS SEK 1.3 MILLION YEAR AGO.

Presbia says terminates nearly half of its workforce

Thursday, 14 Dec 2017

Dec 14 (Reuters) - Presbia Plc ::PRESBIA SAYS TERMINATED 15 EMPLOYEES OUT OF ITS 39 EMPLOYEES - SEC FILING.PRESBIA PLC - "COMPANY IS ALSO IN PROCESS OF IMPLEMENTING OTHER COST SAVING INITIATIVES".

Danaher Sees FY 2018 Adjusted Earnings Per Share $4.25 To $4.35

Thursday, 14 Dec 2017

Dec 14 (Reuters) - Danaher Corp ::DANAHER INITIATES 2018 OUTLOOK.SEES FY 2018 EARNINGS PER SHARE $3.50 TO $3.60.SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.25 TO $4.35.FY2018 EARNINGS PER SHARE VIEW $4.34, REVENUE VIEW $19.09 BILLION -- THOMSON REUTERS I/B/E/S.- SEES 2018 NON-GAAP CORE REVENUE GROWTH BETWEEN 3.5 PERCENT AND 4 PERCENT.

UMS United Medical Systems International H1 EPS Amounts 0.00 eur As Prior Year​

Thursday, 14 Dec 2017

Dec 14 (Reuters) - UMS UNITED MEDICAL SYSTEMS INTERNATIONAL I L AG ::H1 ‍EARNINGS PER SHARE AMOUNTS 0.00 EUR AS PRIOR YEAR​.UMS - ‍H1-END CASH IN BANKS ARE EUR 1.5 MILLION COMPARED TO EUR 1.8 MILLION AT BEGINNING OF FISCAL YEAR​.

Avinger Says Executive Chairman John Simpson Will Be Leaving Company

Monday, 11 Dec 2017

Dec 11 (Reuters) - Avinger Inc ::AVINGER ANNOUNCES CHANGE IN BOARD LEADERSHIP.AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY.AVINGER INC - CONCURRENT WITH SIMPSON'S DEPARTURE, JAMES G. CULLEN HAS BEEN APPOINTED NON-EXECUTIVE CHAIRMAN OF BOARD.

Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc

Monday, 11 Dec 2017

Dec 11 (Reuters) - Neovasc Inc ::CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING.

Revenio Acquires Minority Interest In Oscare Medical

Monday, 11 Dec 2017

Dec 11 (Reuters) - Revenio Group Oyj ::REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY.‍SIGNED AN AGREEMENT TO PURCHASE MINORITY INTEREST IN OSCARE MEDICAL OY, A STAKE OF 46.5% IN COMPANY​.‍FOLLOWING TRANSACTION, REVENIO GROUP CORPORATION WILL OWN 100% OF OSCARE MEDICAL OY​.‍REVENIO WILL MAKE IMPAIRMENT-RELATED ENTRIES IN FINANCIAL STATEMENTS FOR 2017​.- ‍ARRANGEMENT AND IMPAIRMENTS WILL HAVE ONE-OFF EFFECT OF AROUND EUR 1.4 MILLION ON OPERATING PROFIT FOR 2017​.‍ARRANGEMENT WILL HAVE NO EFFECT ON REVENIO'S FINANCIAL GUIDANCE FOR CURRENT YEAR.​.

Restoration Robotics Announces Appointment Of Mark Hair As CFO

Monday, 11 Dec 2017

Dec 11 (Reuters) - Restoration Robotics Inc ::RESTORATION ROBOTICS® ANNOUNCES APPOINTMENT OF MARK HAIR AS CHIEF FINANCIAL OFFICER.RESTORATION ROBOTICS INC - MARK HAIR WILL JOIN COMPANY AS CHIEF FINANCIAL OFFICER, EFFECTIVE JANUARY 5, 2018.RESTORATION ROBOTICS INC - HAIR SUCCEEDS CHARLOTTE HOLLAND, WHO IS STEPPING DOWN FROM HER ROLE AS CFO AND WILL ASSIST IN LEADERSHIP TRANSITION.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary